Docket Room.
A 4924·NJ·house

Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.

In CommitteeFiled May 7, 2026
Sponsor: Stewart, Kenyatta
Latest Action

Introduced First Reading Assembly Referred to AHE

May 7, 2026

Email me when A 4924 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track A 4924. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill directs the New Jersey Department of Health to set up Centers on Rare Kidney Disease Research and to fund them through grants and cooperative agreements. It also requires a statewide study of testing, prevention, precision medicine and treatment for rare kidney diseases, especially in underserved communities. $10 million from the General Fund is allocated, and the program runs for five years.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about A 4924

3 free questions a day, no account

History

  1. Introduced, Referred to Assembly Health Committee

Sponsors

  • Stewart, Kenyatta · sponsor
  • Kearney, Vincent M.
  • Speight, Shanique

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when A 4924 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track A 4924 free

Or ask your AI assistant about A 4924 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice